— Know what they know.
Not Investment Advice

EMGE OTC

Emergent Health Corp
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -0.0% 1Y: +0.0% 3Y: -88.2% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $4193 mcap · Short 84% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.000300000014
Volume100,000
Avg Volume28,778
Beta-8.39
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJames W. Zimbler
Employees6
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2009-09-08
10120 Valley Forge Circle
King of Prussia, PA 19406
US
484-518-9000
About Emergent Health Corp

Emergent Health Corp. focuses on the creation and distribution of advanced regenerative medicine, alongside a variety of nutraceuticals and plant-derived nutritional supplements. The company's product portfolio features Vita-Stim, a potent nutrient formulated to strengthen the immune system, promote stem cell vitality, and support general well-being. Another key offering is Neuvitale, which not only assists in nourishing stem cells but also serves as a methyl donor to safeguard DNA integrity. For appetite regulation, they provide Hungarest, a dietary aid designed to manage hunger signals originating from both the brain and stomach. Additionally, EmergentO2 is available as a water oxygenator, aiming to elevate oxygen levels within the bloodstream. The firm also develops and markets several solutions for diminishing facial wrinkles. These products are distributed through a wide network of health food stores, pharmacies, and diverse other retail channels, reaching consumers throughout the United States and globally. Based in King of Prussia, Pennsylvania, Emergent Health Corp. transitioned to private ownership as of August 26, 2014.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms